Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 11/20 | 0.82 |
| ▸ | AKT1 | P31749 | 9/20 | 0.82 |
| ▸ | AKT2 | P31751 | 9/20 | 0.82 |
| ▸ | AKT3 | Q9Y243 | 9/20 | 0.82 |
| ▸ | PIK3CB | P42338 | 11/20 | 0.80 |
| ▸ | PIK3CD | O00329 | 3/20 | 0.80 |
| ▸ | PIK3CG | P48736 | 3/20 | 0.80 |
| ▸ | SRC | P12931 | 1/20 | 0.80 |
| ▸ | DDX6 | P26196 | 1/20 | 0.80 |
| ▸ | PDE4A | P27815 | 1/20 | 0.80 |
| ▸ | CSK | P41240 | 1/20 | 0.80 |
| ▸ | MTOR | P42345 | 1/20 | 0.80 |
| ▸ | PLK1 | P53350 | 1/20 | 0.80 |
| ▸ | PRKDC | P78527 | 1/20 | 0.80 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.80 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.80 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.80 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.80 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.80 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25414825 | 1.00 | PIK3CA (0.82) | PIK3CAAKT1AKT2AKT3PIK3CB | |
| SCHEMBL26136960 | 1.00 | PIK3CA (0.82) | PIK3CAAKT1AKT2AKT3PIK3CB | |
| SCHEMBL30780741 | 1.00 | PIK3CA (0.82) | PIK3CAAKT1AKT2AKT3PIK3CB | |
| SCHEMBL27116441 | 0.94 | PIK3CA (0.84) | PIK3CAAKT1AKT2AKT3PIK3CB | |
| SCHEMBL26136962 | 0.94 | PIK3CA (0.84) | PIK3CAAKT1AKT2AKT3PIK3CB | |
| SCHEMBL30780666 | 0.94 | PIK3CA (0.84) | PIK3CAAKT1AKT2AKT3PIK3CB | |
| SCHEMBL26136961 | 0.94 | PIK3CA (0.84) | PIK3CAAKT1AKT2AKT3PIK3CB | |
| SCHEMBL25415277 | 0.93 | PIK3CA (0.82) | PIK3CAAKT1AKT2AKT3PIK3CB | |
| SCHEMBL25415273 | 0.93 | PIK3CA (0.82) | PIK3CAAKT1AKT2AKT3PIK3CB | |
| SCHEMBL26137362 | 0.93 | PIK3CA (0.82) | PIK3CAAKT1AKT2AKT3PIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078120-A1 | SUBSTITUTED PYRIDOPYRIMIDINONES | Mirati Therapeutics, Inc. (US) | 2026-03-19 | — | — | US | claimed |
| EP-4577544-A1 | SUBSTITUTED PYRIDOPYRIMIDINONES | Mirati Therapeutics, Inc. (US) | 2025-07-02 | — | — | EP | claimed |
| WO-2024044769-A1 | SUBSTITUTED PYRIDOPYRIMIDINONES | Mirati Therapeutics, Inc. (US) | 2024-02-29 | — | — | WO | claimed |
| US-20260078120-A1 | SUBSTITUTED PYRIDOPYRIMIDINONES | Mirati Therapeutics, Inc. (US) | 2026-03-19 | — | — | US | disclosed |
| EP-4577544-A1 | SUBSTITUTED PYRIDOPYRIMIDINONES | Mirati Therapeutics, Inc. (US) | 2025-07-02 | — | — | EP | disclosed |
| WO-2024044769-A1 | SUBSTITUTED PYRIDOPYRIMIDINONES | Mirati Therapeutics, Inc. (US) | 2024-02-29 | — | — | WO | disclosed |
| WO-2023078401-A1 | COMPOUNDS AS PROTEIN KINASE INHIBITORS | FOCHON BIOSCIENCES, LTD. (CN) | 2023-05-11 | — | — | WO | disclosed |
| WO-2023081209-A1 | PI3K INHIBITORS AND METHODS OF TREATING CANCER | ZENO MANAGEMENT, INC. (US) | 2023-05-11 | — | — | WO | disclosed |
| WO-2023081209-A1 | PI3K INHIBITORS AND METHODS OF TREATING CANCER | ZENO MANAGEMENT, INC. (US) | 2023-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078120-A1 | SUBSTITUTED PYRIDOPYRIMIDINONES | CBR1, CBR3, CNR1 | PIK3CA 2749/4885AKT1 2105/4885AKT2 2550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.